ArticleFrontiers in oncology2025

Efficacy and safety of TACE combined with TKIs and PD-1 inhibitors in HCC patients with prior TIPS.

Kai Xiong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.